Pegasystems Announces Second Quarter 2017 Financial Results
Aug 09, 2017 20:02 pm UTC| Business
License and Cloud Backlog increases 32% year over yearFirst half revenue growth of 15% coupled with operating margin expansion Record operating cash flow of $86 million in first half of 2017 CAMBRIDGE, Mass., Aug. 09,...
FutureFuel Releases Second Quarter and Six-Month 2017 Results
Aug 09, 2017 20:02 pm UTC| Business
FutureFuel Second Quarter Net Income of $0.8 Million Reports Net Income of $0.8 Million or $0.02 per Diluted Share, and Adjusted EBITDA of $2.1 Million CLAYTON, Mo., Aug. 09, 2017 -- FutureFuel Corp. (NYSE:FF)...
Tractor Supply Company Announces Groundbreaking of Northeast Distribution Center
Aug 09, 2017 20:01 pm UTC| Business
BRENTWOOD, Tenn., Aug. 09, 2017 -- Tractor Supply Company (NASDAQ:TSCO), the largest rural lifestyle retail store chain in the United States, announced today it has officially begun construction of a new distribution...
Retrophin Reports Second Quarter 2017 Financial Results
Aug 09, 2017 20:01 pm UTC| Business
Fosmetpantotenate (RE-024) Phase 3 trial underway in PKAN Protocol design for pivotal Phase 3 trial of sparsentan in FSGS complete; sparsentan IP estate expanded to 2030 for FSGS Second quarter revenues increased 16...
Aclaris Announces Proposed Public Offering of Common Stock
Aug 09, 2017 20:01 pm UTC| Business
MALVERN, Pa., Aug. 09, 2017 -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led, biopharmaceutical company, today announced that it intends to offer and sell, subject to market conditions, up to $75,000,000...
Westell Reports Fiscal First Quarter 2018 Revenue of $16.6M
Aug 09, 2017 20:01 pm UTC| Business
AURORA, Ill., Aug. 09, 2017 -- Westell Technologies, Inc. (NASDAQ:WSTL), a leading provider of high-performance wireless infrastructure solutions, announced results for its fiscal 2018 first quarter ended June 30, 2017...
BeiGene Reports Second Quarter 2017 Financial Results
Aug 09, 2017 20:01 pm UTC| Business
CAMBRIDGE, Mass. and BEIJING, China, Aug. 09, 2017 -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical company developing innovative molecularly targeted and immuno-oncology drugs for the treatment of...